National Institutes of Health grant notices posted in 2025, now closed
75 National Institutes of Health grant notices posted on Grants.gov in 2025 that have closed, with their numbers and dates.
- RFA-HG-25-012: Limited Competition: Outcomes of Electronic Medical Records and Genomics (eMERGE) Genomic Risk Assessment and Management Network - Clinical Sites (U01, Clinical Trial Required)
- RFA-DK-26-308: Limited Competition Renewal for the Continuation of the Liver Cirrhosis Network: Clinical Research Centers (U01 Clinical Trial Required)
- RFA-OD-25-012: Informatics, Coordination and Service Center for the Mutant Mouse Resource and Research Centers (U42 Clinical Trial Not Allowed)
- RFA-DK-26-306: Engineering Improved Stem Cell-Derived Islet Cells for Replacement Therapies (R01 - Clinical Trial Not Allowed)
- RFA-CA-25-032: Cancer Intervention and Surveillance Modeling Network (CISNET) (U01 Clinical Trial Not Allowed)
- RFA-DA-26-020: Dynamic and Adaptable Infrastructure for Drug Development and Outreach to Aid the Research Community in Advancing Medication Repurposing and Repositioning Efforts for Substance Use Disorders (SUDs) (U54 - Clinical Trials Not Allowed)
- RFA-AI-25-012: Rational Design of Vaccines Against Hepatitis C Virus (U19 Clinical Trial Not Allowed)
- RFA-RM-25-006: Pilot Projects to Enhance the Human Virome Program (R03, Clinical Trials Not Allowed)
- RFA-HD-26-001: Development of Novel or Improved Infertility Technologies (R61/R33 Clinical Trial Optional)
- RFA-AI-25-013: Limited Competition: National Biocontainment Laboratories (NBLs) Operations Support (UC7 Clinical Trials Not Allowed)
- RFA-HL-26-006: Viral INfections in the Young Lung- The VINYL Clinical Consortium (UG3/UH3 Clinical Trial Optional)
- RFA-HL-26-008: Viral INfections in the Young Lung- The VINYL Clinical Consortium- Data Analytics and Coordinating Center (DACC)(U24 Clinical Trial Optional)
- RFA-MH-26-195: Optimizing Treatment Strategies for Adult Attention-Deficit Hyperactivity Disorder (ADHD) (R01 Clinical Trial Required)
- RFA-DK-26-315: Advancing Research on the Application of Digital Health Technology to the Management of Type 2 Diabetes (R01- Clinical Trail Required)
- PAR-25-445: NIDCD Clinical Research Center Grant (P50 Clinical Trial Optional)
- RFA-AG-26-025: Claude D. Pepper Older Americans Independence Centers (P30 Clinical Trial Optional)
- RFA-AG-26-007: Artificial Intelligence and Technology Collaboratory Coordinating Center (U24 Clinical Trial Not Allowed)
- RFA-AG-26-006: Artificial Intelligence and Technology Collaboratory (P30 Clinical Trial Optional)
- RFA-AI-25-010: Nonhuman Primate Reagent Resource (U24 Clinical Trial Not Allowed)
- RFA-AT-25-004: NIH Blueprint for Neuroscience: Coordination Center for Interoception Research (BPCCIR) (U24, Clinical Trial Not Allowed)
- RFA-AI-25-035: Influenza Transmission Research Consortium (P01 Clinical Trial Optional)
- RFA-AI-25-018: Mucosal Immunology Studies Team (MIST) (U01 Clinical Trial Not Allowed)
- RFA-AI-25-027: Tuberculosis Research Units (P01 Clinical Trial Optional)
- RFA-AI-25-022: Partnerships for Development of Vaccines to Prevent Mycobacterium tuberculosis Infection and/or Disease (R01 Clinical Trial Not Allowed)
- RFA-AG-26-014: Aging Mammalian Tissues In Vitro (R21 Clinical Trial Not Allowed)
- PAR-25-323: Stephen I. Katz Early Stage Investigator Research Project Grant (R01 Basic Experimental Studies with Human Required)
- RFA-AG-26-002: Single Source: National Centralized Repository for Alzheimer's Disease and Related Dementias (NCRAD) (U24 Clinical Trial Not Allowed)
- RFA-OD-25-008: Tobacco Regulatory Science Small Grant Program for New Investigators (R03 Clinical Trial Optional)
- RFA-AG-26-003: National Alzheimers Coordinating Center (U24 Clinical Trial Not Allowed)
- RFA-AR-25-013: Limited Competition: Regenerative Medicine Innovation Project (RMIP) Investigator-Initiated Studies (U01 Clinical Trial Not Allowed)
- RFA-AR-25-014: Limited Competition: Regenerative Medicine Innovation Project (RMIP) Investigator-Initiated Clinical Trials (UH3 Clinical Trial Optional)
- RFA-AG-26-001: Single Source: National Longitudinal Study of Adolescent to Adult (Add) Health Wave VII (U01 Clinical Trial Not Allowed)
- RFA-RM-25-003: NIH Directors Transformative Research Awards (R01 Clinical Trial Optional)
- RFA-RM-25-001: NIH Directors Pioneer Award Program (DP1 Clinical Trial Optional)
- RFA-RM-25-002: NIH Directors New Innovator Award Program (DP2 Clinical Trial Optional)
- PAR-25-438: Rare Diseases Clinical Research Consortia (RDCRC) for the Rare Diseases Clinical Research Network (RDCRN) (U54 Clinical Trial Optional)
- PAR-24-300: Behavioral and Integrative Treatment Development Program (R34 Clinical Trial Optional)
- RFA-DK-26-009: New Investigator Gateway Awards for Collaborative T1D Research (R03 Clinical Trial Not Allowed)
- PAR-24-333: NIA Predoctoral Fellowship Award to Promote Broad Participation in Translational Research for AD/ADRD (F31 Clinical Trial Not Allowed)
- PAR-24-332: NIA Postdoctoral Fellowship Award to Promote Broad Participation in Translational Research for AD/ADRD (F32 Clinical Trial Not Allowed)
- PAR-25-356: T32 Training Program to Promote Broad Participation (T32 Clinical Trial Not Allowed)
- RFA-AI-24-079: Asthma and Allergic Diseases Cooperative Research Centers (U19 Clinical Trial Optional)
- RFA-HL-26-009: Limited Competition: Clinical Research Sites (CRS) for the MACS/WIHS Combined Cohort Study (MWCCS) (U01 Clinical Trial Not Allowed)
- RFA-HL-26-010: Limited Competition: Data Analysis and Sharing Center (DASC) for the MACS/WIHS Combined Cohort Study (MWCCS) (U01 Clinical Trials Not Allowed)
- RFA-HL-26-011: Leadership and Coordination Center (LACC) for the MACS/WIHS Combined Cohort Study (MWCCS) (U01 Clinical Trials Not Allowed)
- RFA-DK-26-007: Collaborative Research Using Biosamples and/or Data from Type 1 Diabetes Clinical Studies (R01 - Clinical Trial Not Allowed)
- PAR-25-342: Interventions on Health and Healthcare Disparities on Non-Communicable and Chronic Diseases in Latin America: Improving Health Outcomes Across the Hemisphere (R01 - Clinical Trial Required)
- RFA-AI-25-006: Molecular Mechanisms of Combination Adjuvants (MMCA) (R01 Clinical Trial Not Allowed)
- RFA-MH-26-105: Multimodal Artificial Intelligence to Accelerate HIV Clinical Care (R01 Clinical Trial Optional)
- RFA-HL-26-007: Single Source: Bench to Bassinet Congenital Heart disease Advancing New understanding in GEnomics Cohort (B2B CHANGE Cohort) Data Coordinating Center (U01 Clinical Trial Not Allowed)
- PAR-25-312: Time-Sensitive Evaluation of Policies Affecting Health Behaviors and Chronic Disease Risk (R01-Clinical Trial Not Allowed)
- PAR-25-090: NIDDK High Risk Multi-Center Clinical Study Implementation Planning Cooperative Agreements (U34 Clinical Trial Optional)
- PA-25-169: Trailblazer Award for New and Early Stage Investigators (R21 Clinical Trial Optional)
- PA-25-150: Joint NINDS/NIMH Exploratory Neuroscience Research Grant (R21 Clinical Trial Not Allowed)
- PAR-25-354: Multidisciplinary Studies of HIV/AIDS and Aging (R01 Clinical Trial Optional)
- PAR-25-355: Multidisciplinary Studies of HIV/AIDS and Aging (R21 Clinical Trial Optional)
- PAR-25-319: Advancing HIV/AIDS Research within the Mission of the NIDCD (R01 Clinical Trial Optional)
- PAR-25-318: Advancing HIV/AIDS Research within the Mission of the NIDCD (R21 Clinical Trial Optional)
- PAR-25-097: Small Grants for New Investigators to Broaden Participation in Health-Related Research (R21 Clinical Trial Optional)
- PAR-25-048: Prospective Observational Comparative Effectiveness Research in Clinical Neurosciences (UG3/UH3 Clinical Trial Not Allowed)
- PAR-25-377: Unveiling Health and Healthcare Disparities in Non-Communicable and Chronic Diseases in Latin America: Setting the Stage for Better Health Outcomes Across the Hemisphere (R01 - Clinical Trials Not Allowed)
- PAS-25-102: Small R01s for Clinical Trials Targeting Diseases within the Mission of NIDDK (R01 Clinical Trial Required)
- RFA-NR-25-004: Understanding the Intersection of Social Inequities to Optimize Health and Reduce Health Disparities: The Axes Initiative (R01 Clinical Trial Optional)
- PAR-24-329: Development and Testing of Novel Interventions to Improve HIV Prevention, Treatment, and Program Implementation for People Who Use Substances (R34 Clinical Trial Required)
- RFA-AT-25-002: Limited Competition: Advancing the Science of Complementary and Integrative Health Approaches to Improve Maternal Health Outcomes (R01 Clinical Trial Required)
- RFA-RM-24-013: Complement-ARIE New Approach Methodologies (NAMs) Data Hub and Coordinating Center (U24 Clinical Trial Optional)
- PAR-25-335: NEI Translational Research Program for Therapeutics (R61/R33 Clinical Trial Not Allowed)
- PAR-25-363: NEI Translational Research Program for Therapeutics (R33 Clinical Trial Not Allowed)
- RFA-DC-25-003: Cooperative Agreement for In Vivo High-Resolution Imaging for Inner Ear Visualization (U01 Clinical Trial Required)
- RFA-DC-25-005: In Vivo High-Resolution Imaging for Inner Ear Visualization (R01 Clinical Trial optional)
- PAR-25-328: Grand Opportunity in Medications Development for Substance-Use Disorders (U01 Clinical Trial Optional)
- PAR-25-329: Development of Medications to Prevent and Treat Substance Use Disorders and Overdose (UG3/UH3 - Clinical Trial Optional)
- PA-25-147: NIDDK High Risk Multi-Center Clinical Study Cooperative Agreement (U01 Clinical Trial Required)
- PAR-25-089: NIDDK High Risk Multi-Center Clinical Study Cooperative Agreement (U01 Clinical Trial Not Allowed)
- PAR-25-347: Substance Use/Substance Use Disorder Dissertation Research Award (R36 Clinical Trials Not Allowed)